TITRE |
Un registre exhaustif et observationnel des néoplasies myéloprolifératives dans la province du Québec (Registre des NMP) |
PROTOCOLE ID |
Registre des NMP (CINC424BCA04T) |
CLINICAL TRIAL.gov ID |
|
TYPE(S) DE CANCER |
NMP : Vaquez , Thrombocythémie essentielle, Métaplasie myéloide |
PHASE |
Autres |
TYPE D'ÉTUDE |
|
INSTITUTION |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
5415 boul. de l'Assomption
(514) 252-3400
|
VILLE |
Montréal
|
INVESTIGATEUR(RICE) PRINCIPAL(E) |
Lambert Busque
|
COORDONATEUR(RICE) |
Michel-Olivier Gratton mogratton.hmr@ssss.gouv.qc.ca 514-252-3400 poste 2397
|
STATUT |
Actif en recrutement
|
CRITÈRES D'ÉLIGIBILITÉ |
(EN) All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
- Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
- Are 18 years of age or older;
- Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
|
CRITÈRES D'EXCLUSION |
(EN) Patients who meet any of the following criteria will be excluded from participation:
- Life expectancy of less than 3 months for a condition not related to MPN;
- Patients suffering of CML.
|